SCHEMBL3134963

SCHEMBL3134963

COc1ccc([S+](c2ccccc2)c2ccc(OC)cc2)cc1.FC(F)(F)c1cc([B-](c2cc(C(F)(F)F)cc(C(F)(F)F)c2)(c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR1H4 Q96RI1 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
AHR P35869 1/20 0.37
DHFR P00374 2/20 0.37
MAPT P10636 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PPARG P37231 1/20 0.36
RUVBL1 Q9Y265 1/20 0.36
MAOB P27338 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
ACP1 P24666 1/20 0.36
CA4 P22748 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
ACHE P22303 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3136188 1.00 RAB9A (0.40) RAB9AL3MBTL1NR1H4HSP90AA1HSP90AB1
SCHEMBL3136015 0.89 NPSR1 (0.41) RAB9AL3MBTL1NR1H4MAPTTDP1
SCHEMBL3244276 0.87 TSHR (0.41) RAB9AL3MBTL1MAPTALDH1A1GAA
SCHEMBL3137494 0.86 TACR1 (0.34) DHFRALDH1A1
SCHEMBL3139294 0.85 KIF11 (0.46) L3MBTL1MAPTALDH1A1GAA
SCHEMBL3144568 0.85 KIF11 (0.46) L3MBTL1MAPTALDH1A1GAA
SCHEMBL3139818 0.84 NFE2L2 (0.39) DHFRMAPTALDH1A1GAATDP1
SCHEMBL3132670 0.84 NFE2L2 (0.39) DHFRMAPTALDH1A1GAATDP1
SCHEMBL3140013 0.83 LTA4H (0.42) L3MBTL1ALDH1A1PPARGPTGDR2
SCHEMBL3130125 0.83 KIF11 (0.37) L3MBTL1MAPTALDH1A1GAAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7642368-B2 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-01-05 US disclosed
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2007-04-12 US disclosed
EP-1676835-A1 PROCESS FOR PRODUCING TRIARYLSULFONIUM SALT Wako Pure Chemical Industries, Ltd. (JP) 2006-07-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070083060-A1 for use as acid generator in semiconductor manufacture; triarylsulfonium salt having a structure that only one aromatic ring of three is different, in a high yield and by-product inhibition; reacting a diaryl sulfoxide with an aryl Grignard reagent in presence of chlorotrialkylsilane and strong acid ARSA, HAO2, HAO1 RAB9A 1824/4885L3MBTL1 3389/4885NR1H4 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.